1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Title

Showing 1,267 results.

ALL - 1320

Comparative Performance of Multimodal Large Language Models in Acute Leukemia Morphology

Miranda Lin

Poster Presenter: Miranda Lin

ABCL - 100

Comparative Pharmacovigilance of CD20-Directed Bispecific Antibodies in B-Cell Lymphoma: A FAERS Observational Study

Edward Mwarangu

Poster Presenter: Edward Mwarangu

$Thumbnail for Comparative Real-World Efficacy and Safety of 4-1BB-based (Liso-Cel/Tisa-Cel) vs CD28-Construct Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis$

SOHO 2026 Annual Meeting

Posters by Title

Comparative Performance of Multimodal Large Language Models in Acute Leukemia Morphology

Comparative Pharmacovigilance of CD20-Directed Bispecific Antibodies in B-Cell Lymphoma: A FAERS Observational Study

Comparative Real-World Efficacy and Safety of 4-1BB-based (Liso-Cel/Tisa-Cel) vs CD28-Construct Containing (Axi-Cel) CAR T-Cell Therapy for Relapsed/Refractory Large B-Cell Lymphomas: A Meta-Analysis

Comparative Real-World Outcomes of CAR T-Cell Therapy vs Bispecific Antibodies in Relapsed/Refractory Multiple Myeloma: A Propensity-Matched TriNetX Analysis

Comparative Real-World Outcomes of CAR-T Therapy Versus Standard Systemic Therapy in Diffuse Large B-Cell Lymphoma

Comparative Safety of Ibrutinib vs. Acalabrutinib in Chronic Lymphocytic Leukemia: A Propensity-Score-Matched Analysis of Real-World Outcomes

Comparative Toxicity of Menin Inhibitor-Based Combination therapy in newly diagnosed Acute Myeloid Leukemia: Venetoclax-containing Versus Non-Venetoclax regimens

Comparing Ibrutinib With Acalabrutinib and Zanubrutinib in B Cell Malignancies: A Real-World Study of Mortality and Toxicity

Comparison of Adverse Effects in 6 FDA approved CAR-T therapies